Menu
Recruiting NCT06272786

Suprascapular Nerve Block in Patients Rehabilitated After Arthroscopic Rotator Cuff Repair

No phase Interventional Rotator Cuff Tears Pain Nerve Block

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: conventional physiotherapy program., Suprascapular nerve block.
Who it may be relevant to
Registry conditions: Rotator Cuff Tears, Pain, Nerve Block. Basic parameters: 18 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

The Effect of Suprascapular Nerve Block in Patients Rehabilitated After Arthroscopic Rotator Cuff Repair: Randomized Controlled Study

Overview

Suprascapular nerve block is an injection method that has been shown to be effective in shoulder rehabilitation in diseases such as adhesive capsulitis and stroke .. Applying the block under USG guidance instead of blinding increases the effectiveness and reduces complications.

Detailed description

Suprascapular nerve block is an injection method that has been shown to be effective in shoulder rehabilitation in diseases such as adhesive capsulitis and stroke .Applying the block under USG guidance instead of blinding increases the effectiveness and reduces complications There are many studies in the literature on suprascapular, axillary, and interscalene nerve blocks in early pain management after shoulder arthroplasty. All of these focus on pain in the perioperative or early postoperative period. There is a study on USG-guided suprascapular nerve block. In this study, unlike the studies in the literature, it was aimed to show the effectiveness of USG-guided suprascapular nerve block in the subacute rehabilitation process of patients.

Interventions

  • Procedure conventional physiotherapy program.
    It will be applied to a rehabilitation program including joint range of motion exercises and physical therapy modalities by a physiotherapist at the Physical Therapy Hospital.
  • Procedure Suprascapular nerve block
    Bupivacaine hydrochloride will be used in this injection. 5 ml of bupivacaine hydrochloride 5% and 5 ml of saline will be drawn into a 10 ml syringe and ejection will be performed from the superior of the suprascapular noch under USG guidance.

Primary outcome measures

  • Visual Analog Scale (VAS) [Time frame: Baseline]
  • Visual Analog Scale (VAS) [Time frame: 6th week]
  • Visual Analog Scale (VAS) [Time frame: 10th week]
  • Shoulder joint range of motion (ROM) [Time frame: Baseline]
  • Shoulder joint range of motion (ROM) [Time frame: 6th week]
  • Shoulder joint range of motion (ROM) [Time frame: 10 th week]
Secondary outcome measures (6)
  • Shoulder Pain and Disability Index (SPADİ) [Time frame: Baseline]
  • Shoulder Pain and Disability Index (SPADİ) [Time frame: 6th week]
  • Shoulder Pain and Disability Index (SPADİ) [Time frame: 10th week]
  • Modified Constant-Murley Scoring [Time frame: 6th week]
  • Modified Constant-Murley Scoring [Time frame: 10th week]
  • Modified Constant-Murley Scoring [Time frame: Baseline]

Eligibility criteria

Inclusion criteria

-Having undergone arthroscopic rotator cuff repair surgery within the last week

Exclusion criteria

  • History of previous surgery on the same shoulder
  • History of systemic inflammatory rheumatological disease
  • Neurological diseases with muscle weakness in the upper extremity (MS, ALS, Muscular -Dystrophy)
  • History of malignancy, pregnancy, breastfeeding
  • Use of steroids or immunosuppressive drugs
  • History of allergic reactions to local analgesics
  • Fibromyalgia syndrome
  • Chronic painful conditions that require opioid use
  • Presence of known psychiatric disease
  • Cognitive impairment (Mini Mental Test Score <23)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

Turkey (Türkiye) · 1 center
  • Ahi Evran University — Kirşehir

Identifiers

NCT: NCT06272786 · 2023-18/128

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗